MedPage Today on MSN6h
GLP-1 Drugs and Colonoscopy; GI Symptoms Post-COVID; Identifying High-Risk Barrett'sA systematic review and meta-analysis of five studies suggested that patients on GLP-1 receptor agonists were more likely to ...
Crohn’s disease isn’t just about digestion. From joint pain to vision issues, its hidden symptoms affect the body in unexpected ways.
A special liquid diet, known as exclusive enteral nutrition, is an essential therapy for Crohn's disease. Patients consume ...
Palisade Bio, Inc. announced positive preclinical results for its drug candidate PALI-2108 at the 2025 Crohn’s and Colitis Congress, showing its efficacy in reducing colitis symptoms in a DSS ...
Microbiome as a potential key to better treatment: Clinical study on new therapy for Crohn's disease
A special liquid diet, known as exclusive enteral nutrition, is an essential therapy for Crohn's disease. Patients consume only this formula for six to eight weeks, completely avoiding solid foods.
Let's dive deep into a topic that isn’t getting enough shine – Crohn's disease and how it's hitting the Black community.
4d
Data presented at the 2025 Crohn’s and Colitis Congress PALI-2108 demonstrated to effectively reduce colitis symptoms in DSS mouse model without ...
News Medical on MSN3d
Study explores microbiome reboot to prolong effect of Crohn's disease therapyA special liquid diet, known as exclusive enteral nutrition, is an essential therapy for Crohn's disease. Patients consume ...
Crohn's disease can cause symptoms unrelated to your digestion. Health's Crohn's Disease Advocate Gaylyn Henderson, MPH, describes the early symptoms of Crohn's disease she had—and none of them ...
Eli Lilly has shared positive two-year results from an open-label extension (OLE) study of Omvoh (mirikizumab-mrkz) in active ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback